Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1253/circj.CJ-66-0117 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum apixaban
4
apixaban treatment
4
treatment japanese
4
japanese subjects
4
subjects acute
4
acute venous
4
venous thromboembolism
4
thromboembolism amplify-j
4
amplify-j study
4
corrigendum
1
Similar Publications
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].
J Thromb Haemost
December 2024
Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota, USA.
Corrigendum to < IN-VITRO APIXABAN REMOVAL BY CYTOSORB® WHOLE BLOOD ADSORBER. AN EXPERIMENTAL STUDY.> <[Journal of Cardiothoracic and Vascular Anesthesia 36/6 (2024) 1636 - 1644]>.
J Cardiothorac Vasc Anesth
July 2024
Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway. Electronic address:
Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
Thromb Res
December 2021
Department of Medicine, Universidad Autónoma de Barcelona, Spain; Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!